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In recent years, extracellular vesicles (EVs), such as exosomes
and microvesicles have been attracting attention as an informa-
tion source for the development of new diagnostic and treat-
ment methods. With regard to the history of exosomes,
Johnstone RM et al. had discovered ﬁne particles of approxi-
mately 50 nm in size released from sheep reticulocytes, which
were later termed ‘exosomes’.1 Lotvall J et al. reported in 2007,
approximately 30 years after the original discovery,1 that RNA,
such as microRNA (miRNA) and mRNA, is present in the exo-
somes and that these may be used for cell-to-cell transportation
of miRNA. This report resulted in an immediate focus on exo-
some research.2 Exosomes and microvesicles have various com-
mon features, e.g. they are both EVs, approximately 100 nm in
size, covered by a lipid bilayer membrane, and contain proteins
and RNA in the vesicles3; however, the production processes
are signiﬁcantly different. Exosomes are formed during the pro-
duction of endolysosomes by the fusion of endosomes and lyso-
somes; on the other hand, microvesicles are released outside
from the cells following budding from the cell membrane. Exo-
somes contain Testis-speciﬁc gene 10, Heat shock protein70
and tetraspanins, such as CD9, CD63 and CD81; furthermore,
they contain proteins such as p53, epidermal growth factor and
ﬁbroblast growth factor. Because methods for the precise distinc-
tion between exosomes and microvesicles have not been estab-
lished, they are often collectively termed EVs.3 In this article,
EVs that are secreted into the airway are abbreviated as
airway-secreting EVs (AEVs). Because information in the extra-
cellular vesicles RNA (evRNA) contains intracellular information
associated with the cellular response to the pathology of the
recipient cells, it is the focus for a new source of biomarkers.4
Sampling of the airway mucosa and the lung tissue is difﬁcult;
therefore, evRNA is beneﬁcial because useful information can
be obtained non-invasively. In this study, we used a mouse
model of asthma induced by the house dust mite (HDM)
allergen. AEVs were collected after allergen exposure. By per-
forming a comprehensive analysis of mRNA proﬁling within
AEVs, we examined the usefulness of mRNA as pathological bio-
markers of AEVs.
Our group has previously reported an experimental method for
a mouse asthma model induced by HDM allergen.5 C57BL/6J micePeer review under responsibility of Japanese Society of Allergology.
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licenses/by-nc-nd/4.0/).were administered either 2.0 mg/ml (100 mg/mouse) HDM extract
(Greer Laboratories, Lenoir, NC, USA) dissolved in phosphate-
buffered saline (PBS) or PBS alone (sham control) 3 times (day 1,
8 and 15). Each group included 4 mice. Seventy-two hours after
ﬁnal administration, bronchoalveolar lavage ﬂuid (BALF) was
collected (Fig. 1A). Isolation of AEVs from BALFs, was performed us-
ing ExoQuick Exosome Precipitation Solution (System Biosciences,
Mountain View, CA, USA), according to the manufacturer's recom-
mended protocol. Brieﬂy, BALFs centrifuge at 4 C (450 g,
10 min) to remove BAL cells and subsequently at 3000 g
(15 min) to remove dead cells. The supernatants were ﬁltered
through 0.2-mm ﬁlters to remove particulate material larger than
200 nm and centrifuged at 3000 g for 15 min. After RNA prepara-
tion from AEVs, RNA libraries were prepared using the Ion Total
RNA-Seq Kit v2 (Invitrogen Life Technologies, Carlsbad, CA, USA)
following the manufacturer's recommended protocol. Sequencing
of each sample was performed on the Ion Torrent PGM instrument
using 318 chips (11,000,000 wells per chip) according to the proto-
col provided in the Total evRNA and Protein Isolation Kit (Invitro-
gen) with 500 ﬂows (125 cycles). The expression proﬁles of AEVs
mRNA were analysed by the Partek® Genomics Suite 6.5 software
program (Partech, Munster, Germany). To identify the list of the
genes upregulated by HDM allergen and signalling pathways
possibly involved in their gene upregulation, we used Ingenuity
Pathway Analysis (IPA) software (Ingenuity® Systems; http://
www.ingenuity.com).
ThemRNA proﬁling within AEVs after 72 h of ﬁnal HDM allergen
exposure was analysed using the Partek® Genomics Suite 6.5 soft-
ware. The results are shown in a heat map (Fig. 1A) and a volcano
plot (Fig. 1B). We observed that HDM allergen stimulation
increased mRNA expression in 235 genes compared with the
sham control. Further, we analysed the 235 genes using the IPA
software; expression levels of these genes were signiﬁcantly
elevated (p < 0.05) and showed a 2-fold increase after 72 h of
HDM stimulation compared with the sham control. We attempted
to identify upstream regulatory molecules of the genes expressed
in AEVs. Using IPA software analysis, we identiﬁed IL-4 (activation
z-score 2.211, p value of overlap 1.38E-03) and IL-13 (activation z-
score 2.351, p value of overlap 2.32E-04) as upstream regulator
molecules of RNA in AEVs induced by HDM stimulation, with
high conﬁdence.
Th2 cytokines, such as IL-4 and IL-13, are critical factors in the
development of allergic airway inﬂammation.6e8 In our experi-
mental model, we observed IL-4 and IL-13 elevation in BALF
(data not shown). Among the genes induced by HDM allergen,vier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
Fig. 1. Summary of genome-wide mRNA proﬁles of airway secreting extracellular ves-
icles (AEVs) in house dust mite (HDM)-treated or sham-control mice. (A) A hierarchical
clustering analysis was performed on the basis of the expression patterns observed.
Genes were linked together according to their expression levels (dendrogram, left
panel). HDM-treated mice (yellow bar); sham control mice (blue bar). Gene-
expression intensities were standardized between 2.0 (blue) and þ2.0 (red). (B) Vol-
cano plot showing gene expression levels in AEVs from HDM-treated vs. sham-control
mice (n ¼ 4).
Table 1
The list of genes suspected to be regulated by IL-4 or IL-13.
IL-4 predicted to be activated.
(z-score 1.896) Overlap p-value 4.80E-04
Gene Expression fold change
Retnla 411.113
Apoe 199.636
Ext1 17.220
Pydc4 11.168
Oprm1 7.879
Ccrn4l 7.271
Cmah 6.447
Pfkp 6.136
Il33 5.055
Cd40 5.040
Scgb3a1 4.296
Hsd3b2 3.716
Ablim1 2.710
IL-13 predicted to be activated.
(z-score 2.351) Overlap p-value 2.30E-04
Gene Expression fold change
Retnla 411.113
Oprm1 7.879
Sprr2a2 7.262
Qsox1 6.878
Pfkp 6.136
Hdc 5.630
Cd40 5.040
Scgb3a1 4.296
Hsd3b2 3.716
Chi3l1 2.323
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stream of IL-4 and IL-13 were 13 and 10, respectively, according
to IPA software analysis (Table 1). Of these, 6 genes (Cd40,
Scgb3a1, Hsd3b2, Retnla, Oprm1 and Pfkp) were overlapped be-
tween IL-4 and IL-13. This might be because IL-4 and IL-13 bind
to both a-chains of the IL-4 receptor.9 Although pathophysiolog-
ical roles of these genes on allergic inﬂammation are largely un-
known, an EV-included mRNA gene regulated by IL-13, CHI3L1,
which encodes the YKL-40 protein, is associated with asthma
severity.10 CD40 and Retnla have been reported to increase in mu-
rine asthma model.11 In addition, the interaction between CD40
and its ligand is crucial for IL-12 production and effective humou-
ral immunity such as IgE production.11 These evidences suggest
that the transport of mRNA genes regulated by IL-4 and IL-13 to
recipient cells via EVs might be involved in the development of
allergic immune responses.
Among the genes upregulated in AEVs by HDM allergen expo-
sure, the presence of IL-33, which is one of the IL-4 regulated
genes, has drawn our attention. IL-33 was increased 5.055-fold
in AEVs after HDM allergen exposure. IL-33, which is released
from epithelial cells, and other cytokines, i.e. thymic stromallymphopoietin (TSLP) and IL-25, that are produced from the
airway and intestinal epithelium are collectively termed “epithe-
lial derived cytokines”.12e14 IL-33 protein is generally present in
the nucleus and is a transcriptional repressor. IL-33 is cleaved by
activated caspase-3 and caspase-7 in cells undergoing apoptosis,
the ability to bind to IL-33 receptors is lost.13,15 However, cells un-
dergoing necrosis release full-length IL-33, which activates im-
mune cells that express IL-33 receptors. Natural helper (NH)
cells that secrete large amounts of Th2-type cytokines through
the action of IL-33 have been discovered in the visceral fat tissue
of mice. This demonstrates that IL-33 could induce allergic inﬂam-
mation by direct stimulation of eosinophil, basophil and mast cells
without activating Th2 cells.16 Thus, the function of IL-33 has
attracted attention as a novel allergic inﬂammatory mecha-
nism.17,18 It has been reported that among evRNA, mRNA trans-
ports RNA into EVs of recipient cells, resulting in protein
expression. In this study, the identiﬁcation of the presence of IL-
33 gene in EVs suggests that expression of transmitted danger
signal molecules by EVs in recipient cells could affect the immune
response. In future, the role of immune regulatory molecules such
as those in EVs requires to be elucidated.
In summary, we considered that the genetic information in EVs
secreted in the respiratory tract contains molecular biological infor-
mation associated with asthma pathogenesis and that genetic anal-
ysis of AEVs will be useful for pathological analysis. Moreover, the
presence of genes that cause inﬂammation in EVs suggests that
these genes may have a new immunomodulatory function through
recipient cells. Because the role of AEVs in allergic inﬂammation
remains unclear, further studies are required to elucidate the
function.Conﬂict of interest
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